Olin Corporation

Olin Corporation (OLN) Market Cap

Olin Corporation has a market capitalization of $2.80B.

Price: $24.54

โ–ผ -0.39 (-1.56%)

Market Cap: 2.80B

NYSE ยท time unavailable

CEO: Kenneth Todd Lane

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 1987-12-30

Website: https://www.olin.com

Olin Corporation (OLN) - Company Information

Market Cap: 2.80B|Sector: Basic Materials

Company Profile

Olin Corporation manufactures and distributes chemical products in the United States, Europe, and internationally. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, chlorinated organics intermediates and solvents, and sodium hypochlorite. The Epoxy segment provides epoxy materials and precursors, including aromatics, such as acetone, bisphenol, cumene, and phenol, as well as allyl chloride, epichlorohydrin, and glycerin used for the manufacturers of polymers, resins and other plastic materials, and water purification; liquid and solid epoxy resins that are used in adhesives, marines, protective coatings, composites, and flooring; and converted epoxy resins and additives for use in electrical laminates, paints and coatings, wind blades, electronics, and construction. The Winchester segment offers sporting ammunition products, including shotshells, small caliber centerfire, and rimfire ammunition products for hunters and recreational shooters, and law enforcement agencies; small caliber military ammunition products for use in infantry and mounted weapons; and industrial products comprising gauge loads and powder-actuated tool loads for maintenance applications in power and concrete industries, and powder-actuated tools in construction industry. The company markets its products through its sales force, as well as directly to various industrial customers, mass merchants, retailers, wholesalers, other distributors, and the U.S. Government and its prime contractors. Olin Corporation was incorporated in 1892 and is based in Clayton, Missouri.

Analyst Sentiment

52%
Hold

From 14 Active Polls

1Y Forecast: $27.70

โ–ฒ +12.9% Potential Upside

Consensus Target Metrics

Low Bound

$22

Median

$26

High Bound

$37

Average

$28

Price & Moving Averages

Loading chart...

๐ŸŽฏ Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$27.70
โ–ฒ +12.88% Upside
Low Target
$22.00
-10% Risk
Median Target
$26.00
6% Mid
High Target
$37.00
51% Max
Consensus
Hold
12 / 35 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

๐Ÿ“Š Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)2,7953,3832,3732,8712,3122,7953,9825,6095,513
Enterprise Value ($M)5,8536,4415,5976,0355,3735,9516,9568,5888,570
Price to Earnings Ratio (P/E)-21.99-10.19-6.9216.69-444.68499.0893.03-56.3118.57
Price/Earnings-to-Growth Ratio (PEG)โ€”โ€”โ€”โ€”-64.08โ€”18.08โ€”34.91
Price to Sales Ratio (P/S)0.422.141.421.681.321.702.383.533.35
Price to Book Ratio (P/B)1.611.951.251.461.181.391.972.732.58
Price to Free Cash Flow Ratio (P/FCF)9.22-36.669.18-64.6712.75-18.9643.9038.26161.66
Enterprise Value to Sales (EV/Sales)โ€”4.073.363.523.063.624.165.405.21
Enterprise Value to EBITDA (EV/EBITDA)11.47112.61114.2226.6530.2732.0635.9753.5730.81
Debt to Equity Ratio5.991.871.791.681.681.661.561.561.52

โšก OLN Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$24.54
Intrinsic Value$59.41
Market Alignment
Undervalued by 142.1%relative to calculated intrinsic value
9.00%
Exp: -6%-6%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

๐Ÿง  Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.70B
Perpetuity TV Value$13.19B
Discounted TV (PV)$5.57B
TV Weighting %53.5%
โš ๏ธ
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

๐Ÿ“˜ Full Research Report

โ„น๏ธ

AI-Generated Research: This report is for informational purposes only.

๐Ÿ“˜ OLIN CORP (OLN) โ€” Investment Overview

๐Ÿงฉ Business Model Overview

Olin operates two distinct, economically linked segments: chlor-alkali and vinyls and ammunition. In chlor-alkali/vinyls, Olin converts basic inputs into high-volume industrial chemicals through an integrated value chain: brine and electricity drive chlor-alkali production (including chlorine and caustic soda), which then supports downstream vinyls chemistry (notably vinyl chloride-related products used to create PVC and other derivatives). This integration reduces dependency on external sourcing for key feedstocks and enables more stable conversion economics across the chain. In ammunition, Olin produces propellants and finished cartridges for civilian and defense end markets, leveraging manufacturing know-how, controlled chemistry inputs, and long-lived distribution relationships.

๐Ÿ’ฐ Revenue Streams & Monetisation Model

Revenue is primarily transactional and tied to prevailing commodity and product-cycle pricing for chemicals, with some customer contracting and indexation structures depending on product and customer requirements. Ammunition sales are also largely order-driven, including government and commercial channels, with pricing that reflects product specifications, component costs, and service levels.

The main margin drivers in chlor-alkali/vinyls are:

  • Energy and raw material cost positioning (electricity intensity and brine/logistics economics).
  • Feedstock-to-product conversion economics (the relationship between chlorine/caustic pricing and downstream vinyl economics).
  • Plant utilization and operating reliability (chemicals are capacity- and downtime-sensitive).

In ammunition, margin drivers include:

  • Component procurement discipline (powder/metal inputs and process yields).
  • Manufacturing scale and throughput (fixed-cost absorption).
  • Product mix and specifications (defense vs. commercial and caliber mix).

๐Ÿง  Competitive Advantages & Market Positioning

Olinโ€™s moat is primarily rooted in cost advantage and logistics in energy/materials, supported by operational integration. While chemicals compete on price, cost position and reliability matter materially because customers generally value stable supply and predictable quality.

1) Geographic cost advantage & infrastructure-driven production economics

Chlor-alkali and vinyls are heavy, utilities- and logistics-intensive businesses. Olin benefits from an industrial footprint that supports efficient sourcing of inputs and distribution of outputs, reducing landed costs versus producers with weaker proximity to cost-effective utilities, transportation routes, or supply nodes.

2) Integration reduces external exposure

Integration from chlor-alkali into vinyls helps reduce reliance on third-party pricing for key intermediates and supports better capture of favorable cycle conditions across the value chain when spreads are constructive.

3) Ammunition manufacturing know-how and industrial process discipline

In ammunition, barriers are operational rather than purely intellectual-property-based: consistent chemistry control, quality systems, and scalable production lines reduce the risk of supply shortfalls for customers that require specification compliance and delivery reliability.

  • Chemicals competitors: Westlake Chemical, Shintech (Chevron/Total ecosystem historically active in vinyls), and Formosa Plastics.
  • Ammo competitors: Vista Outdoor/Federal Ammunition, and major specialty cartridge manufacturers such as Hornady.

Contrast vs. rivals: many vinyls competitors emphasize different mixes of upstream/downstream exposure and geographic siting. Olinโ€™s positioning emphasizes integrated chemistry economics paired with industrial logistics and energy economics, while ammunition peers compete on capacity, component supply execution, and distribution reach rather than on similar upstream integration. This creates a different competitive lens: Olinโ€™s advantage in chemicals is primarily cost/infrastructure; in ammunition it is primarily operational scale and execution quality.

๐Ÿš€ Multi-Year Growth Drivers

Over a 5โ€“10 year horizon, growth is expected to be driven less by one-off capacity events and more by structural end-market demand and chemical intensity trends:

  • End-market durability for caustic soda and related chemicals: demand anchored in alumina refining, water treatment and industrial chemical production that tends to be less discretionary than many consumer categories.
  • PVC-linked infrastructure and replacement cycles: construction, pipe and building products markets benefit from long-lived assets and repair/renewal needs.
  • Resilient defense and training demand dynamics for ammunition: defense procurement cycles and ongoing training requirements support a baseline that can outlast short-lived civilian fluctuations.
  • Operational excellence as a compounding driver: in cyclical businesses, disciplined maintenance, uptime, and cost controls convert industry cycles into better long-run average performance for the most efficient operators.

TAM expansion in chemicals tends to be incremental and demand-led, while ammunition growth is more tied to utilization of firearm platforms and procurement patterns. In both cases, Olinโ€™s long-run value proposition depends on maintaining cost and reliability through the cycle.

โš  Risk Factors to Monitor

  • Commodity and spread volatility: chlor-alkali and vinyls economics can swing with global capacity additions, pricing cycles, and feedstock/energy input movements.
  • Energy and utility cost sensitivity: electricity and related industrial utility costs can compress margins for producers with weaker power contracts or higher intensity.
  • Regulatory and environmental compliance: chemical operations face ongoing environmental permitting, emissions controls, and waste-treatment requirements that can require incremental capex.
  • Capacity and competitive dynamics: new entrants or expansions in vinyls and adjacent chemicals can shift supply-demand balances and pressure pricing.
  • Policy and legal risks in ammunition: firearms-related regulation, export controls, product liability, and litigation can alter demand patterns and distribution economics.
  • Capital intensity and turnaround execution risk: sustaining reliability in heavy chemical assets requires maintenance discipline and periodic turnarounds; execution variability can impact production and cash flow.

๐Ÿ“Š Valuation & Market View

Valuation for Olin typically reflects the cyclicality of industrial chemicals and the operational execution of industrial manufacturing. In practice, market multiples often track earnings power rather than accounting earnings, with EV/EBITDA and similar frameworks used to normalize through-cycle performance.

Key valuation drivers include:

  • Ability to preserve margin through cost cycles (energy/input cost position and reliability).
  • Downstream conversion economics (vinyls/intermediate relationships and demand strength for PVC-linked products).
  • Utilization and maintenance outcomes that affect cash conversion and earnings stability.
  • Cash discipline and capital allocation, particularly in businesses where periodic capex and turnarounds influence free cash flow.

Because both segments are exposed to industrial cycles, the market tends to underwrite companies with demonstrably stronger cost positions and operational execution that can sustain better average profitability across varying conditions.

๐Ÿ” Investment Takeaway

Olinโ€™s long-term investment case centers on structural cost advantages and integrated operating economics in chlor-alkali/vinyls, supported by industrial logistics and reliability. The ammunition segment provides additional diversification through manufacturing scale and execution in a regulated/contracted end market. The main debate for investors is not demand growth alone, but whether Olin can maintain its cost and uptime advantages through cyclical swings while managing regulatory and capital requirements.


โš  AI-generated โ€” informational only. Validate using filings before investing.

๐Ÿ“ฐ Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for OLN.

gurufocus.comโ€ข2026-06-04

Olin Corp (OLN) Stock Down 3.2% -- Now Undervalued? GF Score: 65/100

On June 04, 2026, Olin Corp (OLN) shares fell 3.2% today, currently trading at $24.93. This price movement is particularly notable given the stock's 52-week ran

gurufocus.comโ€ข2026-05-29

Is Olin Corp (OLN) a Bargain After 3.3% Drop? GF Value Says Undervalued

On May 29, 2026, Olin Corp (OLN) shares fell 3.3% to a current price of $25.87, reflecting a broader trend as the stock has decreased 4.8% over the past month.

marketbeat.comโ€ข2026-05-14

Olin Q1 Earnings Call Highlights

Olin NYSE: OLN executives said the company expects a sharp sequential improvement in second-quarter earnings as higher pricing, seasonal demand and cost reductions begin to flow through results following a challenging but improving first quarter.

zacks.comโ€ข2026-05-12

Olin Posts Narrower-Than-Expected Q1 Loss, Revenues Down Y/Y

OLN beat Q1 loss estimates and topped sales forecasts as Winchester growth offset weaker Chemicals demand and margin pressure.

seekingalpha.comโ€ข2026-05-08

Olin Corporation (OLN) Q1 2026 Earnings Call Transcript

Olin Corporation (OLN) Q1 2026 Earnings Call Transcript

zacks.comโ€ข2026-05-07

Olin (OLN) Reports Q1 Loss, Tops Revenue Estimates

Olin (OLN) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of $0.67. This compares to earnings of $0.04 per share a year ago.

zacks.comโ€ข2026-05-07

Olin (OLN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Olin (OLN) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

prnewswire.comโ€ข2026-05-07

Olin Announces First Quarter 2026 Results

Highlights First quarter 2026 net loss of ($83.0) million, or ($0.73) per diluted share Quarterly adjusted EBITDA of $86.2 million CLAYTON, Mo., May 7, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced financial results for the first quarter ended March 31, 2026.

zacks.comโ€ข2026-04-30

Olin (OLN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Olin (OLN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

seekingalpha.comโ€ข2026-04-07

Olin: Improving Margins By Factoring Cost Savings

Olin is expected to implement one of its largest cost-saving goals this year, estimated to be between $100 and $120 million. Given that we are starting to see top line recovery, mainly driven by the epoxy segment, cost savings will bring margin expansion. Momentum, growth, and profitability metrics are improving well and are superior to its peers, but the valuation remains depressed with an upside potential of 68% in case of a re-rating.

seekingalpha.comโ€ข2026-04-05

Olin: Results May Be Bottoming

Olin remains a buy as Middle East conflict tightens global petrochemical supply, supporting US-centric producers and improving pricing power. OLN's Q1 likely marks the bottom, with Q2 expected to benefit from lower US natural gas prices and improved margins, especially in Chlor Alkali. Despite weak construction demand, supply disruptions and cost tailwinds should drive at least $150M free cash flow in 2026, with further upside possible.

prnewswire.comโ€ข2026-04-02

Olin Corporation First Quarter 2026 Earnings Conference Call Announcement

CLAYTON, Mo., April 2, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced today that on Friday, May 8, 2026, at 9:00 a.m.

prnewswire.comโ€ข2026-03-30

Innovent's Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema

OLN324 demonstrated meaningfully faster and greater improvements in anatomic outcomes in DME and numerically greater vision gains sustained through 20 weeks with fewer retreatments as compared to faricimab New anatomic data demonstrates OLN324 achieves faster, greater, and more durable reductions in wAMD pigment epithelial detachment (PED) thickness versus faricimab Ollin and Innovent Biologics adva ncing OLN324 into global Phase 3 studies inย DME and wAMD in 2026 SAN FRANCISCO and SUZHOU, China, March 30, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, today announced that the company's partner Ollin reported final, 20-week study completion data from its randomized, head-to-head Phase 1b JADE clinical study comparing OLN324(Innovent R&D code IBI324) , a higher-potency, smaller-format, higher-molar dose VEGF/Ang2 bispecific antibody, to faricimab (Vabysmoยฎ), in patients with diabetic macular edema (DME) or wet (neovascular) age-related macular degeneration (wAMD). Final results released include favorable durability data for OLN324 compared to faricimab and new anatomic data showing faster, greater, and more durable control of wAMD pigment epithelial detachments (PEDs) with OLN324.

defenseworld.netโ€ข2026-03-30

SG Americas Securities LLC Grows Stock Position in Olin Corporation $OLN

SG Americas Securities LLC raised its position in Olin Corporation (NYSE: OLN) by 142.0% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 455,757 shares of the specialty chemicals company's stock after acquiring an additional 267,458 shares during the quarter.

prnewswire.comโ€ข2026-03-06

U.S. Defense Manufacturers Face A Rare Earth Supply Squeeze - OilPrice.com Market Commentary

/PRNewswire/ -- According to sources, the Pentagon will prohibit the use of rare earth magnet materials originating from China in U.S. military platforms

๐Ÿ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"OLN reported Q1 2026 revenue of $1.583B and net income of -$83.0M (EPS -$0.73). On a YoY basis, revenue declined to 2026-03-31 from $1.644B in 2025-03-31 (about -3.7% YoY), while net income deteriorated from +$1.4M to -$83.0M (down roughly -6.1k%). QoQ, revenue also softened versus Q4 2025 ($1.665B) by about -4.9%, and net income worsened from -$85.7M to -$83.0M (slightly better by ~-3.2% QoQ). Profitability is under pressure: net margin was -5.2% in Q1 2026, down from +0.1% in Q1 2025, with operating margin -4.9% (negative). Cash flow quality is mixed. Operating cash flow was reported as $0 for the quarter, while free cash flow was -$43.7M after $22.8M in dividends and ~$43.7M of capex. Balance sheet resilience remains relatively solid with total assets $7.35B and equity $1.73B; however leverage is elevated with total debt about $3.25B and net debt about $3.06B. Shareholder returns are supportive: the stock is up 28.1% over the last year (+dividend yield ~0.7%), indicating strong capital appreciation despite current losses. Analyst valuation appears constructive with a consensus target of ~$24.33 versus price ~$26.09 (modestly below spot)."

Revenue Growth

Caution

Revenue was $1.583B in Q1 2026, down ~-3.7% YoY (vs. $1.644B in Q1 2025) and ~-4.9% QoQ (vs. $1.665B in Q4 2025), indicating a weakening trajectory.

Profitability

Neutral

Net income fell to -$83.0M in Q1 2026 from +$1.4M in Q1 2025; net margin was -5.2% vs ~+0.1% prior-year. Negative operating and net margins suggest contraction persists.

Cash Flow Quality

Caution

Operating cash flow was reported as $0 in Q1 2026, while free cash flow was -$43.7M. Dividends remained paid (-$22.8M), consistent with support of shareholder yield despite earnings losses.

Leverage & Balance Sheet

Positive

Balance sheet size is stable (assets ~$7.35B) and equity remains large (~$1.73B). Leverage is high (net debt ~ $3.06B; debt-to-capitalization ~0.65), but there is no sharp equity erosion in the quarter.

Shareholder Returns

Good

Total return backdrop is positive: 1Y price change of +28.1% plus a ~0.7% dividend yield. The >20% momentum meaningfully boosts the score despite fundamentals deteriorating.

Analyst Sentiment & Valuation

Caution

Consensus price target (~$24.33) is below the current price (~$26.09), implying limited upside versus spot and reflecting caution as profitability is negative.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Olinโ€™s Q1 2026 call centers on a CAPV-driven recovery narrative with an operational caveat. Management guided Q2 adjusted EBITDA to $160โ€“$200 million versus ~$86 million in Q1, citing the bulk of the ~$100 million-plus sequential improvement from CAPV: higher volumes as Freeport restarts, and improved caustic/EDC pricing momentum. Beyond two fifty continues to underpin the cost story, with $44 million of structural savings delivered in 2025 and $100โ€“$120 million expected in 2026, but it is not presented as the main earnings bridge. The key near-term risk is an unplanned Freeport vinyls outage; management says Q2 includes an estimated impact and that vinyls restart is planned late next week, tied to safe root-cause remediation. Outside CAPV, epoxy is back to profitability with meaningful price actions and Europe cost restructuring, while Winchester momentum is returning via commercial pricing traction and retail-to-OTD alignment. Overall outlook is constructive, but execution/timing risk remains salient.

AI IconGrowth Catalysts

  • CAPV earnings rebound expected from improved chlor-alkali pricing and higher volumes as Freeport vinyls restart enables ECU production
  • Epoxy business returned to profitability with expected full-year improvement driven by Europe cost restructuring and higher North America/Europe resin pricing
  • Winchester commercial ammunition momentum: retail shipments realigning with out-the-door sales supporting mid- to high-single-digit YoY commercial volume uplift
  • Structural pricing support from Gulf Coast advantage as Middle East disruptions tighten global supply and freight constraints persist

Business Development

  • Strategic relationship with Braskem (EDC) cited as accretive through the cycle; portfolio includes both contracted and spot EDC exposure
  • Chemours 2028-plus period agreement: long-term supply deal (no disclosed economics) positioned as accretive and expanded relationship
  • Freeport โ€œfence-line customerโ€ agreement extension described as a priority option for vinyl strategy

AI IconFinancial Highlights

  • Adjusted EBITDA guidance for Q2: $160 million to $200 million (Q1 referenced at ~$86 million; midpoint guidance implies ~+$100 million sequential uplift)
  • Beyond two fifty structural cost program: $44 million structural savings delivered in 2025; incremental $100 million to $120 million expected in 2026
  • CAPV Q1 benefited from lower operating costs driven by Beyond two fifty and lower-than-expected maintenance/turnaround costs
  • Vinyls outage at Freeport: Q2 outlook includes estimated impact; restart expected late next week (unplanned vinyls outage not included in the Q2 turnaround expense forecast)
  • Domestic caustic soda price increases: $185 per ton announced for implementation in 2026; continued aggressive balance of price announcements
  • Epoxy price actions: March+April increases totaling >$1,200 per ton in North America and โ‚ฌ1,300 per metric ton in Europe (to offset higher feedstock and transportation costs)

AI IconCapital Funding

  • Liquidity: 1.3 billion of available liquidity maintained; revolving credit facility access stated as full after February amendment for covenant flexibility through late 2027
  • No maturities before 2029; net debt/leverage increased in Q1 due to seasonal working capital needs
  • Expect net debt to rise during 2026 to resolve legacy litigation matters
  • 2026 capital spending targeted at approximately $200 million (sustaining capex for safe/reliable operations)
  • Tax cash flow: 2026 expected to be essentially cash-free taxes (plus/minus $20 million) assuming refunds tied to Section 45V clean hydrogen credits
  • Expected year-end debt leverage ratio: just above 4x; goal to average below 2x leverage across the cycle; excess cash (after priorities) to reduce outstanding debt

AI IconStrategy & Ops

  • Beyond two fifty operational execution: nearly doubled Freeport, Texas time-on-tools; maintenance planning transformed from reactive time-based scheduling to proactive risk-based approach using historical data and AI
  • Headcount actions: reduced site headcount by 15% while reducing reliance on contractors and improving reliability
  • CAPV: manage against supply tightness and pricing through asset integration and restart timing
  • Winchester: disciplined make-to-demand model to build commercial backlog while tightly managing working capital; channel inventory rebalance actions executed in H2 2025

AI IconMarket Outlook

  • Q2 adjusted EBITDA expected at $160 million to $200 million
  • Freeport vinyls assets expected restart late next week (reflected in Q2 outlook)
  • EDC and caustic soda pricing expected to stabilize at higher levels vs earlier in the year as shortages persist and production costs remain high
  • Pricing momentum expected: caustic and EDC remain โ€œelevatedโ€ vs start-of-Q1 expectations, with continued momentum into Q3 and later in the year (despite moderation after spikes)

AI IconRisks & Headwinds

  • Unplanned vinyls outage at Freeport: incremental impact to Q2 earnings; restart timing/safety completion is a key variable
  • Turnaround/maintenance costs: Q2 expected to still carry headwinds related to turnarounds even with improved pricing/volume
  • Raw material cost pressure for Winchester (copper, brass, propellants) expected to persist through the year even though pricing actions offset the majority of 2026 inflation
  • Global petrochemical supply chain disruption and freight rates disproportionately impacting non-U.S. producers (creating volatility; pricing lags already limited benefit in Q1 but improves outlook for Q2)
  • VINYLS supply constraints: declared force majeure by several Asian vinyl producers; reported 6% to 9% of annual vinyls capacity affected (duration uncertainty)

Q&A: Analyst Interest

  • Topic: Q1-to-Q2 earnings bridgeโ€”how much uplift is CAPV vs Beyond two fifty and Middle East-driven opportunities. Management emphasized CAPV as the largest driver from improved pricing and higher volumes as assets run again, plus net cost benefits and planned outage timing; Beyond two fifty supports costs but is not the primary bridge.
  • Topic: EDC pricing outlook sensitivity and whether Q2 embeds specific price levels; also how much volume/value is tied to Braskem vs spot. Management said EDC is managed for optionality: Braskem is accretive and contracted, but they balance spot and longer-term exposure to optimize value through the cycle.
  • Topic: Operational clarity on Freeport EDC/VCMโ€”relation between planned turnaround and the unplanned vinyls outage, and impact to Q2. Management confirmed completion of the planned turnaround ahead of schedule and restart of VCM assets; the separate unplanned vinyls-down event triggered root-cause analysis, with restart planned late next week.

Sentiment: MIXED

Note: This summary was synthesized by AI from the OLN Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

๐Ÿ“‹ Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for OLN.

SEC EDGAR Live Feed
Loading financial data and tables...
๐Ÿ“

SEC Filings (OLN)

ยฉ 2026 Stock Market Info โ€” Olin Corporation (OLN) Financial Profile